- Pharmaceutical companies
- South America
- Ecuador
- Novartis
Novartis in Ecuador
Addresses:
-
Novartis Ecuador S.A., Av. Amazonas N37-39 y, Unión Nacional de Periodistas, Edificio Eurocenter - Piso 2, Quito, Ecuador
Phone: 593 2 399 0000
Fax: 593 2 399 0001
-
Novartis Ecuador S.A., Site Guayaquil, Av. Carlos Julio Arosemena Km 2.5 y las Monjas, Edificio Berlin - Piso 2, Guayaquil, Ecuador
Phone: 593 4 220 2700
Other Novartis's locations around the world
-
Switzerland
-
Austria
-
Germany
-
Slovenia
-
Poland
-
France
-
Spain
-
Belgium
-
Romania
-
Italy
-
United Kingdom
-
Ukraine
-
Russia
-
Serbia
-
Slovakia
-
Sweden
-
Belarus
-
Bulgaria
-
Croatia
-
Czech Republic
-
Denmark
-
Estonia
-
Finland
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Latvia
-
Lithuania
-
Luxembourg
-
Macedonia
-
Malta
-
Montenegro
-
Netherlands
-
Norway
-
Portugal
-
Albania
-
Bosnia & Herzegovina
Clinical Trials sponsored by Novartis
-
Novartis PharmaceuticalsNot yet recruitingMultiple Sclerosis, Relapsing-Remitting
-
Novartis PharmaceuticalsNot yet recruitingRheumatoid Arthritis | Systemic Lupus Erythematosus | Sjögrens Disease
-
Novartis PharmaceuticalsNot yet recruitingElevated Lp(a) and Established Atherosclerotic Cardiovascular Disease
-
Novartis PharmaceuticalsRecruiting
-
Novartis PharmaceuticalsRecruiting
-
Novartis PharmaceuticalsNot yet recruitingMultiple Sclerosis
-
Novartis PharmaceuticalsRecruitingMultiple Sclerosis (MS)France
-
Novartis PharmaceuticalsNot yet recruiting
-
Novartis PharmaceuticalsRecruiting
-
Novartis PharmaceuticalsRecruitingCoronary Heart Disease | Clonal Hematopoiesis of Indeterminate Potential (CHIP)Germany, Canada
About Novartis
Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our purpose is to reimagine medicine to improve and extend people's lives. We use innovative science and technology to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company.